GEN Exclusives

More »

GEN News Highlights

More »
Mar 16, 2009

Roche Acquires Innovatis for $19.56M

  • Roche is taking over innovatis, a provider of automated cell analysis solutions, for €15 million, or $19.56 million. The firm focuses on cell counting, viability testing, and cell function analysis in research as well as bioproduction.

    The transaction is expected to be completed within the next few weeks. Innovatis will become a fully-integrated part of Roche Applied Science.

    "This acquisition is a further step in our strategy to strengthen our position as a complete solution provider in the cell analysis research market,” says Jürgen Schwiezer, Ph.D., CEO of Roche Diagnostics. “Innovatis’ technology will complement the existing Roche cell analysis portfolio and is synergistic to the xCELLigence technology launched in 2008.”

     



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?